BioInnovation Capital

Eric Linsley is Managing General Partner at BioInnovation Capital, where he oversees fund operations, manages the North Carolina laboratory, and invests in therapeutics, laboratory tools, diagnostics, and devices. He previously spent over two decades at Pappas Ventures in Durham, North Carolina, where he sourced and managed investments in numerous life sciences companies, including Peninsula Pharmaceuticals (acquired by Johnson & Johnson), Cerexa (acquired by Forest Laboratories), and public companies such as LipoScience, Liquidia, and Ultragenyx. Prior to Pappas Ventures, he served as Chief Financial Officer of AutoCyte and TriPath Imaging, a medical device company acquired by Becton Dickinson in 2006.